A.R.T. Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
A.R.T. Advisors's RCKT Position: Q1 2020 in Review
A.R.T. Advisors sold out of Rocket Pharmaceuticals (RCKT) in Q1 2020, closing a stake of 20,075 shares — an estimated $457K sold.
A.R.T. Advisors first reported a position in RCKT in Q1 2016 and held it in 11 quarters. The position peaked at $1.85M in Q1 2018. 107 funds tracked by Wall St. Rank hold RCKT as of Q1 2020.
- A.R.T. Advisors reported no remaining Rocket Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- A.R.T. Advisors sold 20,075 Rocket Pharmaceuticals shares in Q1 2020, an estimated $457K.
- A.R.T. Advisors first reported a position in Rocket Pharmaceuticals in Q1 2016 and held it in 11 quarters.
- A.R.T. Advisors's Rocket Pharmaceuticals position peaked at $1.85M in Q1 2018.
- 107 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2020.
Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.